Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-26-285563

Chief Financial Officer sold 3,013 shares at $45.03 ($135,675)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Roberts Brandi Chief Financial Officer 2026-06-25 Sale 10b5-1 −3,013 $45.03 $135,675 209,487 D: show line 1 in the form
Open-market sales · 3,013 sh · avg $45.03 · $135,675
Loading xslF345X06/ownership.xml…